Background First described in Uganda over seven decades ago, Endomyocardial fibrosis
(EMF) is a rare form of restrictive cardiomyopathy found in the tropics. EMF occurs mainly in …

Background Endomyocardial fibrosis (EMF) is a restrictive cardiomyopathy, the prevalence
of which is declining globally. This study was carried out to determine if there were changing …

Background: Endomyocardial fibrosis (EMF), an obliterative cardiomyopathy of uncertain
etiology, is the most common restrictive cardiomyopathy worldwide with no specific …

Background Endomyocardial fibrosis is the most common restrictive cardiomyopathy
worldwide. It has no specific treatment and carries a poor prognosis, since most patients …

Objective: Endomyocardial fibrosis (EMF) is a rare disease and is often an underdiagnosed
and forgotten cardiomyopathy. The objective of this study was to document the current …

Endomyocardial fibrosis is a form of endemic restrictive cardiomyopathy that affects mainly
children and adolescents, and is geographically restricted to some poor areas of Africa …

Endomyocardial fibrosis (EMF) continues to be an important and disabling disease in many
parts of Africa, although its prevalence has declined in some parts of the continent …

Often termed as 'vanishing mystery'epidemiologically, endomyocardial fibrosis (EMF)
continues to be the the most common cause of restrictive cardiomyopathy in Africa and some …

Background Endomyocardial fibrosis (EMF) represents the most common cause of restrictive
cardiomyopathy worldwide. Despite a high prevalence in tropical regions, it occasionally …

Endomyocardial fibrosis (EMF), one of the world's most neglected cardiovascular diseases,
remains an important cause of restrictive cardiomyopathy. Worldwide prevalence is …